Planta Med 2007; 73(8): 748-754
DOI: 10.1055/s-2007-981542
Pharmacology
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Cytotoxicity, Apoptosis and DNA Damage Induced by Alpinia galanga Rhizome Extract

P. Muangnoi1 , M. Lu2 , 3 , J. Lee2 , A. Thepouyporn1 , R. Mirzayans2 , X. C. Le3 , M. Weinfeld2 , S. Changbumrung1
  • 1Department of Tropical Nutrition and Food Science, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
  • 2Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
  • 3Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada
Weitere Informationen

Publikationsverlauf

Received: May 10, 2006 Revised: May 3, 2007

Accepted: May 5, 2007

Publikationsdatum:
05. Juli 2007 (online)

Abstract

Alpinia galanga, or galangal, has been a popular condiment used in Thai and Asian cuisine for many years. However, relatively little is known of the potential beneficial or adverse health effects of this spice. This study was conducted to analyze the capacity of galangal extract to induce cytotoxicity and DNA damage in six different human cell lines including normal and p53-inactive fibroblasts, normal epithelial and tumour mammary cells and a lung adenocarcinoma cell line. We deliberately focused on treatment with the crude aqueous extract of galangal rhizomes, rather than compounds extracted into an organic solvent, to more closely reflect the mode of dietary consumption of galangal. The cell lines displayed a broad range of cytotoxicity. There was no evidence for preferential cytotoxicity of tumour cells, but there was an indication that p53-active cell lines may be more sensitive than their p53-inactive counterparts. The contribution of apoptosis to total cell killing was only appreciable after exposure to 300 μg/mL of extract. Apoptosis appeared to be independent of p53 expression. Exposure to as little as 100 μg/mL galangal extract generated a significant level of DNA single-strand breaks as judged by the single-cell gel electrophoresis technique (comet assay). The three major UV-absorbing compounds in the aqueous extract were identified by mass spectrometry as 1′-acetoxychavicol acetate and its deacetylated derivatives. However, when tested in A549 human lung adenocarcinoma cells, these compounds were not responsible for the cytotoxicity induced by the complete aqueous extract.

References

  • 1 Surh Y J, Ferguson L R. Dietary and medicinal antimutagens and anticarcinogens: molecular mechanisms and chemopreventive potential-highlights of a symbolism.  Mutat Res. 2003;  523 - 4 1-8.
  • 2 Ames B N. The detection of chemical mutagens with enteric bacteria. In: Hollaender A, editor. Chemical mutagens: principles and methods for their detection.  NewYork: Plenum. Press;  1971 267-82.
  • 3 Changbumrung S, Jintaridhi P, Kwanbunjan K. Mutagenicity and antimutagenicity of some food plants.  Ann Nutr Metab. 2001;  45 (suppl 1) 543.
  • 4 Haraguchi H, Kuwata Y, Inada K, Shingu K, Miyahara K, Nagao M. et al . Antifungal activity from Alpinia galanga and the competition for incorporation of unsaturated fatty acid in cell growth.  Planta Med. 1996;  62 308-13.
  • 5 Murakami A S, Ohura S, Nakamura K, Koshimizu K, Ohigashi H. 1′-Acetoxychavicol acetate, a superoxide anion generation inhibitor, potently inhibits tumor promotion by 12-O-tetradecanoylphorbol 13-acetate in ICR mouse skin.  Oncology. 1996;  53 386-91.
  • 6 Ohnishi M, Tanaka T, Makita H, Kawamori T, Mori H, Satoh K. Chemopreventive effect of a xanthine oxidase inhibitor 1′-Acetoxychavicol acetate on rat oral carcinogenesis.  Jpn J Cancer Res. 1996;  87 349-56.
  • 7 Tanaka T, Kawabata K, Kakumoto M, Makita H, Matsunaga K, Mori H. et al . Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1′-acetoxychavicol acetate.  Jpn J Cancer Res. 1997;  88 821-30.
  • 8 Qureshi S, Shah A H, Ageel A M. Toxicity studies on Alpinia galanga and Curcuma longa .  Planta Med. 1992;  58 124-7.
  • 9 van Engeland M, Ramekers F CS, Schutte B, Reutelingsperger C P. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture.  Cytometry. 1996;  24 131-9.
  • 10 Kobayashi H, Sugiyama C, Morikawa Y, Hayashi M, Sofuni T. A comparison between manual microscopic analysis and computerized image analysis in the single cell gel electrophoresis assay.  MMS Commun. 1995;  3 103-15.
  • 11 Barley R DC, Enns L, Paterson M C, Mirzayans R. Aberrant p21(WAF1)-dependent growth arrest as the possible mechanism of abnormal resistance to ultraviolet light cytotoxicity in Li-Fraumeni syndrome fibroblast strains heterozygous for TP53 mutations.  Oncogene. 1998;  17 533-41.
  • 12 Rasouli-Nia A, Karimi-Busheri F, Weinfeld M. Stable down-regulation of human polynucleotide kinase enhances spontaneous mutation frequency and sensitizes cells to genotoxic agents.  Proc Natl Acad Sci USA. 2004;  101 6905-10.
  • 13 Smyth P G, Berman S A, Bursztajn S. Markers of Apoptosis: Methods for elucidating the mechanism of apoptotic cell death from the nervous system.  BioTechniques. 2002;  32 648-65.
  • 14 Faulhaber O, Bristow R G. Basis of cell kill following clinical radiotherapy. In: Sluyser M, editor Application of apoptosis to cancer treatment. New York; Springer Verlag 2005: 293-320.
  • 15 Yang X, Eilerman R G. Pungent principal of Alpinia galangal (L.) Swartz and its applications.  J Agric Food Chem. 1999;  47 1657-62.
  • 16 Lee C C, Houghton P. Cytotoxicity of plants from Malaysia and Thailand used traditionally to treat cancer.  J Ethnopharmacol. 2005;  100 237-43.
  • 17 Janssen A M, Scheffer J J. Acetoxychavicol acetate, an antifungal component of Alpinia galanga .  Planta Med. 1985;  51 507-11.
  • 18 Ito K, Nakazato T, Murakami A, Ohigashi H, Ikeda Y, Kizaki M. 1′-Acetoxychavicol acetate induces apoptosis of myeloma cells via induction of TRAIL.  Biochem Biophys Res Commun. 2005;  338 1702-10.
  • 19 Ito K, Nakazato T, Xian M J, Yamada T, Hozumi N, Murakami A. et al . 1′-Acetoxychavicol acetate is a novel nuclear factor κB inhibitor with significant activity against multiple myeloma in vitro and in vivo .  Cancer Res. 2005;  65 4417-24.

Dr. Michael Weinfeld

Department of Experimental Oncology

Cross Cancer Institute

11560 University Avenue

Edmonton

Alberta T6G 1Z2

Canada

Telefon: +1-780-432-8438

Fax: +1-780-432-8428

eMail: michaelw@cancerboard.ab.ca

>